D7003ZZ
Beam Radiation Bone Marrow to None with None, Electrons Approach
Procedural Specifications
| Clinical Axis | Detail Definition |
|---|---|
| Section | D Radiation Therapy |
| Body System | 7 Lymphatic and Hematologic System |
| Operation | 0 Beam Radiation |
| Body Part | 0 Bone Marrow |
| Approach | 3 Electrons |
| Device | Z None |
| Qualifier | Z None |
Procedure Overview
Beam radiation to the lymphatic and hematologic system delivers external radiation, typically from a linear accelerator, to lymph node regions or hematologic tissue affected by cancers such as Hodgkin lymphoma, non-Hodgkin lymphoma, or localized involvement from leukemia. Treatment is usually planned as a fractionated course given over several weeks, with the total dose divided into smaller daily sessions to maximize tumor control while allowing normal tissue to recover between treatments.
It is used both as primary therapy for certain lymphomas confined to specific nodal regions and as consolidation after chemotherapy to eliminate residual disease in previously bulky sites. Patients typically receive planning imaging beforehand to map the treatment field precisely to the involved nodal chain.
Anatomy & Axis Detail
Bone Marrow
Bone marrow, the soft tissue filling the medullary cavities of bones, is the site of hematopoiesis and a common target when malignant or abnormal blood-forming cells must be suppressed across a broad marrow field, as in preparation for hematopoietic stem cell transplantation or in treating diffuse marrow involvement by leukemia. Because functioning marrow is distributed throughout the axial and sometimes appendicular skeleton, beam radiation here is typically delivered as total body or total marrow irradiation, requiring careful planning to spare adjacent organs such as the lungs, liver, and kidneys while achieving myeloablation or cytoreduction. The marrow's radiosensitivity means even modest doses produce profound, expected cytopenias, and documentation should reflect the intended broad field rather than treatment aimed at a single localized lesion.
Modality Qualifier: Electrons
Electrons identifies electron-beam therapy, which delivers a rapid dose falloff after a limited depth and is favored for superficial tumors, skin cancers, or boosts near the surface such as chest wall or scar treatment. Unlike Photons >10 MeV, which continue depositing dose deep into tissue, electrons spare underlying structures once their range is exhausted, making them the modality of choice when sparing deeper organs matters more than penetration.
Coding & Documentation
Coders need documentation specifying the treatment site (a named lymph node region, spleen, or other hematologic structure), the modality as external beam, and the qualifier describing the type of beam, such as photon or electron therapy, drawn from the radiation oncology treatment plan and daily treatment records.
A common error is coding the diagnosis-driven anatomic site rather than the actual field treated, since radiation fields are often described in oncology shorthand like "mantle field" or "involved-site radiotherapy" that must be translated to the correct body part value. Failing to capture the correct qualifier for beam type is another frequent gap when the treatment summary isn't reviewed closely.